Roy Gulick, MD, Infectious Disease, New York, NY, NewYork-Presbyterian/Weill Cornell

RoyGulickMD

Infectious Disease New York, NY

Professor, Medicine, Weill Cornell Medical College

Dr. Gulick is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gulick's full profile

Already have an account?

  • Office

    Division of Infectious Diseases, Box 125, Weill Cornell Medical College
    1300 York Avenue
    New York, NY 10065
    Phone(212) 746-6320
    Fax(212) 746-8675
  • Is this information wrong?

Education & Training

  • School of Public Health, Harvard University
    School of Public Health, Harvard UniversityM.P.H., 1991 - 1993
  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Infectious Disease, 1990 - 1991
  • New York Presbyterian Hospital -  Columbia Campus
    New York Presbyterian Hospital - Columbia CampusResidency, Internal Medicine, 1986 - 1989
  • Columbia University College of Physicians & Surgeons
    Columbia University College of Physicians & SurgeonsClass of 1986
  • Johns Hopkins University
    Johns Hopkins UniversityB.A., 1978 - 1982

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1988 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Lifetime Achievement Award “for his invaluable contributions in the field of HIV medicine, medical education, and research” HIV Congress, 2012
  • Clinical Educator Award HIV Medical Association, 2012
  • Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • 5-year safety evaluation of maraviroc in HIV-1-infected, treatment-experienced patients  
    Gulick RM, Fatkenheuer G, Burnside R, Hardy WD, Nelson MR, Goodrich J, Mukwaya G, Portsmouth S, Heera JR, JAIDS, 1/1/2014
  • Modeling immunologic endpoints as a function of time of switch to second-line ART with incomplete data on switching times  
    Johnson BA, Ribaudo H, Gulick RM, Eron JJ, Biometrics, 1/1/2013
  • Invasive meningococcal disease in men who have sex with men  
    Simon MS, Weiss D, Gulick RM, Ann Intern Med, 1/1/2013
  • Join now to see all

Press Mentions

  • Attraction Is Not A Choice
    Attraction Is Not A ChoiceMay 1st, 2020
  • The Coronavirus-Obesity Link Examined
    The Coronavirus-Obesity Link ExaminedApril 22nd, 2020
  • NIH Panel Recommends Against Using Hydroxychloroquine with Z-pak to Treat COVID-19
    NIH Panel Recommends Against Using Hydroxychloroquine with Z-pak to Treat COVID-19April 22nd, 2020
  • Join now to see all

Hospital Affiliations